A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
78 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Local Institution - 0154
Buenos Aires, Argentina
Not, yet, recruiting - Local Institution - 0156
Buenos Aires, Argentina
Not, yet, recruiting
- Local Institution - 0076
North Ryde, New South Wales, Australia
Not, yet, recruiting - Genesiscare St Leonards
St Leonards, New South Wales, Australia
Recruiting - Local Institution - 0011
Herston, Queensland, Australia
Not, yet, recruiting - Local Institution - 0074
South Brisbane, Queensland, Australia
Not, yet, recruiting - Local Institution - 0003
Malvern, Australia
Not, yet, recruiting
- Hospital Sirio Libanes
Brasília, Federal District, Brazil
Recruiting
- Local Institution - 0007
Calgary, Alberta, Canada
Not, yet, recruiting - Local Institution - 0009
Montreal, Quebec, Canada
Not, yet, recruiting - Local Institution - 0109
Montreal, Quebec, Canada
Not, yet, recruiting
- Bradfordhill
Santiago, Santiago Metropolitan, Chile
Recruiting - Local Institution - 0105
Santiago, Santiago Metropolitan, Chile
Not, yet, recruiting - Local Institution - 0163
Santiago, Chile
Not, yet, recruiting
- Local Institution - 0052
Cali, Colombia
Not, yet, recruiting
- Local Institution - 0147
Prague, Praha 5, Czechia
Not, yet, recruiting - Local Institution - 0149
Brno, Czechia
Not, yet, recruiting - Local Institution - 0150
Hradec Králové, Czechia
Not, yet, recruiting
- Local Institution - 0044
Helsinki, Etelä-Suomen Lääni, Finland
Not, yet, recruiting - Local Institution - 0029
Turku, Finland
Not, yet, recruiting - Local Institution - 0060
Vantaa, Finland
Not, yet, recruiting
- Local Institution - 0083
Lille, Nord, France
Not, yet, recruiting - Local Institution - 0080
Boredeaux, France
Not, yet, recruiting - Local Institution - 0028
Villejuif, France
Not, yet, recruiting
- Local Institution - 0025
Jena, Thuringia, Germany
Not, yet, recruiting - Local Institution - 0026
Hamburg, Germany
Not, yet, recruiting - Local Institution - 0014
Herne, Germany
Not, yet, recruiting - Local Institution - 0027
München, Germany
Not, yet, recruiting
- Local Institution - 0059
Dublin, Ireland
Not, yet, recruiting - Local Institution - 0062
Dublin, Ireland
Not, yet, recruiting
- Local Institution - 0139
Verona, Veneto, Italy
Not, yet, recruiting - Local Institution - 0073
Milan, Italy
Not, yet, recruiting - Local Institution - 0087
Napoli Campania, Italy
Not, yet, recruiting
- the Cancer Institute Hospital of Jfcr
Koto-ku, Tokyo, Japan
Recruiting - Local Institution - 0078
Toyoma, Toyama, Japan
Not, yet, recruiting - Local Institution - 0172
Fukuoka, Japan
Not, yet, recruiting
- Local Institution - 0046
Monterrey, Nuevo León, Mexico
Not, yet, recruiting - Local Institution - 0048
Oaxaca City, Mexico
Not, yet, recruiting - Local Institution - 0122
Puebla City, Mexico
Not, yet, recruiting - Local Institution - 0049
Tlalpan, Mexico
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Mar 2026
- Primary completion
- 28 Nov 2029
- Completion
- 26 Nov 2031
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 254
- Registry id
- NCT07293351
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.